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Clinical and experimental study. Introduction. Of 
debatable etiology, Recurrent Aphthous Ulcerations (R.A.U), 
is most of the time considered an immunological deficiency. 
Aim: The aim of this paper is to review the literature and 
clinical investigations regarding IgA-s, total proteins salivary 
concentration and basal salivary flow of patients with R.A.U. 
during activity and quiescence. Methodology. Nephelometry 
was used to measure salivary IgA-s; Pyrogallol red was used 
for total salivary proteins and the gravimetrical analysis for 
salivary flow measurement. Results. Results demonstrated a 
significant increase in salivary IgA-s in active lesions in relation 
to quiescence. On the other hand, protein concentration rates 
were similar in both periods. Conclusion. Salivary IgA-s 
can be used as a parameter to study the immune status of 
the oral mucosa. 
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INTRODUCTION
Hipocrates (460-370 a.C.) was the one who, for the 
first time, employed the word “aphtha” (aphtodea)1, co-
ming from the Greek word a p t e i n (ARTEIV), translated 
as “set fire”2. Until today, the etiology of recurrent aphthous 
ulcerations (RAU) remains unknown, although hints of 
its etiologic basis lay on genetic susceptibility, infectious 
agents and alterations in immune mechanics.
Now, the mouth mucosal protection system is well 
known, and gathers a large number of substances respon-
sible for its homeostasis3.
The most important humoral mediator for mucosal 
immunity is secretory IgA4,5, for cooperating with a num-
ber of protection mechanisms6, for presenting greater 
resistance to the proteolytic degradation caused by other 
immuneglobulins7 and for being especially located in the 
digestive and respiratory tracts, which are in close contact 
with the environment8, preventing the uptake of a large 
amount of antigens and precluding an overload in the 
immune system9.
The secretory A immunoglobulins present in sa-
liva are excellent indicators of the oral mucosa immune 
status10-12, nonetheless, clinical-laboratorial comparisons 
of recurrent aphthous ulcerations and the local protecting 
mechanisms involved indicate the need for further studies, 
having in mind the scarce number of papers published 
and contradictory results.
MATERIALS AND METHODS
The present investigation, approved by the Rese-
arch Ethics Committee of the Federal University of Vales 
do Jequitinhonha e Mucuri Dentistry School, counted on 
the participation of twenty patients with prior history of 
recurrent aphthous ulcerations, seen in the department 
of Stomatology of the aforementioned institution. The 
patients were selected regardless of gender, age, race 
or socio-economical situation, who matched the inclu-
sion criteria, such as no chronic systemic diseases, drug 
therapy in the week prior to the exam and recent dental 
treatment. All patients were informed on the procedures 
before entering the research project, and signed an infor-
med consent form.
In order to obtain a sample of total saliva, the pa-
tients were instructed as not to eat or drink (except water) 
for one hour and mouth hygiene at least two hours before 
the procedure. Mouth washing with pure water was carried 
out right before harvesting the samples (between 8 and 10 
am). Sampling time was never above 15 minutes.
Total spontaneous saliva that collected on the oral 
cavity floor was harvested with disposable sterilized Pas-
teur-type pipettes. After harvesting, 1.5ml of each sample 
was placed in coded Eppendorf tubes and centrifuged 
afterwards, in order to reduce bubble and foam, and sto-
red in a refrigerated system (freezer at -20ºC). All patients 
participated in two times during the research. The first was 
when they had active aphthous lesion, and the second was 
when they did not have the lesion (quiescent period).
Biochemical Analysis
Nefphelometry was used in order to quantitatively 
assess salivary IgAs (Behring Nephelometer II, Behring, 
USA) with calibrators and reagents supplied by the ma-
nufacturer. In order to assess total proteins, we used the 
Pyrogallol red (Sensiprotò) and reading carried out by a 
semi-automatic analyzer (550 Express from CIBA - Cor-
ningò).
After harvesting, we carried out spontaneous saliva-
ry flow measures (flow at rest) at the times of active lesion 
and at quiescence. During this evaluation, all patients 
remained seated and relaxed, with their heads down and 
lips slightly open in such a way as to let saliva drool pas-
sively over the lower lip and be collected in a graduated 
beaker of known weight. 5 minutes was taken for each 
sampling. Salivary flow was determined by gravimetric 
analysis13,14.
Statistical Analysis
Comparisons were made between male and female 
patients for each one of the time points (with and without 
aphtha) in relation to the variables’ measures: salivary flow, 
salivary IgA-s and total salivary proteins concentration, 
using the Kruskal-Wallis test. This test compares two or 
more independent samples in relation to a variable of 
interest.
Aiming at comparing samples (at the time points 
with and without aphthae) by gender, in relation to the 
variables’ measures: salivary flow rate, IgA-s and total 
salivary proteins concentration (regardless of gender in 
relation to salivary flow and salivary IgA-s), we used the 
Wilcoxon non-parametric test of paired samples.
All results were considered significant for a signifi-
cance likelihood below 5% (p<0.05) thus, yielding at least 
95% of confidence in the conclusions presented.
RESULTS
Of the selected patients, 12 (60%) were females and 
8 (40%) were males, within an age range between 07 and 
54 years, with a prevalence in the 3rd decade of life (from 
21 to 30 years). As related to age, there were no significant 
differences (p> 0.05) gender wise; in other words, the ages 
of these two groups of patients were similar.
The lesions varied between 1 and 4mm in diameter 
and prevailed on the tongue, gingival-labial notch and 
upper lip, with an average number of 2 (two) lesions per 
patient. 
Predisposing factors reported were: stress, food, 
gastrointestinal disorders, menstrual cycle, family history 
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Table 1. Comparative and descriptive analysis of salivary flow and salivary IgA among patients with and without aphthous lesions, regardless 
of gender.
Descriptive measures (level)
Variable Group n Min. Max. Median Average d.p. p
Salivary flow With aphtha 20 0.18 0.52 0.33 0.34 0.09 0.575
 (ml/min) Without aphtha 20 0.15 0.50 0.38 0.34 0.10 CA = SA
         
Salivary IgA  (mg/dl) With aphtha 20 3.2 17.4 7.5 8.2 3.4 0.001
 Without aphtha 20 3.0 12.0 5.4 6.0 2.3
W/A > 
W/out A
Note: The p value refers to the Paired Wilcoxon Test 
Legend: W/A: with aphtha; and W/out A: without aphtha
Table 2. Descriptive and comparative analysis of the salivary flow analysis, salivary IgA and total salivary proteins level between genders in 
relation to patients with aphthae.
Descriptive measures (level)
Variable Gender n Min. Max. Median Mean s.d. p
Patients with aphtha        
         
Salivary Flow Male 8 0.18 0.50 0.31 0.32 0.10 0.315
Rate (ml/min) Female 12 0.24 0.52 0.37 0.36 0.08 M = F
         
Salivary IgA  (mg/dl) Male 8 3.2 13.0 7.2 7.6 3.0 0.643
 Female 12 4.3 17.4 7.8 8.6 3.8 M = F
         
Total salivary Male 8 36.0 81.1 48.4 51.6 13.7 0.049
proteins (mg/dl) Female 12 24.8 85.0 41.6 42.2 15.5 M > F
Note: p value reflects the Kruskal-Wallis test 
Legend: Gender: M: Male and F: Female
Table 3. Descriptive and comparative analysis of salivary flow, salivary IgA and total salivary protein concentration between the genders, in 
relation to the patients without aphthae.
Descriptive measures (level) 
Variable Gender n Min. Max. Median Mean s.d. p
Patients without 
aphthae
        
        
Salivary Male 8 0.17 0.50 0.34 0.32 0.12 0.561
Flow (ml/min) Female 12 0.15 0.45 0.38 0.35 0.09 M = F
         
Salivary IgA  (mg/dl) Male 8 3.0 12.0 6.7 6.6 2.7 0.263
         
Total salivary Male 8 39.7 81.1 65.9 51.6 12.8 0.014
proteins (mg/dl) Female 12 22.9 85.0 45.9 42.2 10.1 M > F
Note: p value reflects the Kruskal-Wallis test 
Legend: Gender: M: Male and F: Female
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and in some it was not possible to notice any association 
with predisposing factors (no apparent cause). 
Results regarding patients’ salivary flow and IgA-
s level evaluations at the time points with and without 
aphtha, regardless of gender, are presented on (Table 1). 
Notice that there were no statistically significant difference 
between salivary flow mean values of the patients at the 
two time points - active lesion and quiescence. As to total 
protein values at the two time points, gender-related, we 
noticed that for males the values were statistically higher 
(Table 2). On the other hand, the total proteins concentra-
tion was different considering the two time points (activity 
and quiescence) in recurrent aphthous ulcerations (Table 
3). The levels of salivary IgA-s in the results proved to 
be significantly increased at the time of activities of this 
lesion, when compared to results at quiescent periods 
(Table 3).
DISCUSSION
The word “aphtha” has been used both by health 
care professionals as by laymen in order to call any oral 
lesion characterized by pain similar to those caused by 
a burn2.
In this investigation, the term recurrent aphthous 
ulcerations (RAU) was employed in order to avoid confu-
sions with other similar entities.
The diagnosis of RAU is purely clinical, considering 
its semiologic and evolution characteristics15. The histo-
pathology of these ulcerations does not show specificity, 
it was used mainly to rule out the non-aphthous lesions7, 
since it represents the histopathology of a non-specific 
inflammatory process16.
Recurrent aphthous ulcerations are usually classi-
fied as: major, minor and herpetiform, according to their 
clinical manifestations such as number of lesions, location 
and severity17. In our series, the most prevalent type was 
the minor, with onset average time of 5 days.
Spontaneous saliva was preferred over the stimu-
lated flow, since there are already data in the literature 
about the “flow at rest”, and because it is more reliable 
to represent the physiology of oral secretions without the 
interference of external factors.
Despite the small amount, organic substances are 
molecules responsible for a major part of the saliva’s 
biologic functions18; they are part of the immune system 
and may, to some extent, operate independently of the 
general immune system4.
Secretory immunoglobulin A (IgA -s) is an important 
parameter to assess the autoimmune status of the mucosa, 
with the advantage of being measurable by non-invasive 
methods and without patient discomfort19,20. This is the 
major class of immunoglobulin found in mucous secre-
tions, and is responsible for a barrier against a number 
of infectious, environmental allergens and carcinogenic 
substances19, and it also aids in many inborn protection 
mechanisms8.
IgA represents the second most abundant immu-
noglobulin in the human serum and prevails in the saliva 
in its dimeric form (IgA-s) which better resists proteolysis 
in environments such as the mouth21.
IgA deficiency is the most common immune hu-
moral defect in humans, and for the most part, causes 
gastrointestinal and respiratory infections22,23.
If immunity has some regulating effect on the de-
velopment of recurrent ulcers, what is expected is that 
IgA-s be the immunoglobulin that provides protection, 
considering its role in other body parts. 
In this study, we aimed at investigating IgA-s con-
centrations and that of total proteins found in the total 
spontaneous saliva and check to see if they differ during 
the times of quiescence and exacerbation of recurrent 
aphthae.
As a means to check salivary flow variations, which 
could influence IgA-s and total protein levels, we used total 
saliva at rest flow check. Our results showed that there 
were no statistically significant differences between flow 
measures at the times of active lesion and acquiescence 
(table 1). Similar results were obtained from patients with 
RAU when compared to individuals without prior history 
of such lesions24.
We also did not see statistically significant differen-
ces between total protein concentrations in patients with 
and without aphthae.
Now, total protein concentrations did not vary when 
the patients were compared with and without lesions 
(Table 3). Spontaneous and stimulated total saliva flow 
sample analyses showed that salivary flow was lower and 
total protein concentrations were higher in women when 
compared to men13. in the present investigation, when we 
compared total proteins we found higher concentrations (p 
< 0.05) at the two time points (With and Without aphthae) 
in men. On the other hand, salivary flow mean values did 
not present significant difference between genders (accor-
ding to Table 2). It is interesting to notice that, although 
men presented higher concentrations of total proteins 
when compared to women, we noticed that both for men 
and women, total protein concentrations were similar for 
both time points: with and without aphthae. There were 
no statistically significant differences (p>0.05) between 
these two time endpoints (Tables 4 and 5).
As to the salivary IgA-s values, there was a statisti-
cally significant difference (p<0.05) in the values, notice-
ably higher during lesion exacerbation when compared 
to inter-crisis periods (without lesions), as described on 
Table 1. Moreover, Table 3 corroborates these results, that 
is, both for males and females; the salivary flow variable 
in patients with and without aphthae does not differ statis-
tically, while salivary IgA-s levels were statistically higher 
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Table 4. Descriptive and comparative analysis of salivary flow, Salivary IgA and total salivary proteins between patients with and without 
aphthae, insofar as males are concerned.
Descriptive measures (level)
Variable Group n Min. Max. Median Mean value s.d. P
Male patients        
         
Salivary With aphthae 8 0.18 0.50 0.31 0.32 0.10 0.944
flow (ml/min) Without aphthae 8 0.17 0.50 0.34 0.32 0.12 CA = SA
         
Salivary IgA  (mg/dl) With aphthae 8 3.2 13.0 7.2 7.6 3.0 0.021
 Without aphtha 8 3.0 12.0 6.7 6.6 2.7 CA > SA
         
Total Salivary With aphthae 8 36.0 81.1 48.4 51.6 13.7 0.183
Proteins (mg/dl) Without aphthae 8 39.7 81.1 65.9 51.6 12.8 CA = SA
Note: p value is related to the Wilcoxon’s test 
Legend: CA means with aphtha and SA means without aphtha
Table 5. Descriptive and comparative analysis of salivary flow, Salivary IgA and total salivary proteins level between patients with and without 
aphthae, insofar as women are concerned. 
Descriptive measures (level) 
Variable Group n Min. Max. Median Mean value s.d. P
Female patients        
Salivary With aphtha 12 0.24 0.52 0.37 0.36 0.08 0.347
Flow Without aphtha 12 0.15 0.45 0.38 0.35 0.09 CA = SA
         
Salivary IgA With aphtha 12 4.3 17.4 7.8 8.6 3.8 0.011
 Without aphtha 12 3.5 10.2 5.1 5.6 2.1 CA > SA
         
Total salivary With aphtha 12 24.8 85.0 41.6 42.2 15.5 0.255
proteins Without aphtha 12 22.9 85.0 45.9 42.2 10.1 CA = SA
Note: p value is related to the Wilcoxon’s test 
Legend: CA means with aphtha and SA means without aphtha
in patients with aphthae. These data are similar to those 
found in individuals with aphtha and those without prior 
history of this lesion25,26.
A study carried out on salivary IgA-s levels in pa-
tients with RAU at the times of incipient and acute lesion, 
regression and complete cure, showed an increase in 
IgA-s at the acute period, and its reduction in periods of 
regression and cure, and for the women in the group, very 
discrepant results were noticed, in some of them salivary 
IgA-s levels were influenced by menstrual cycle and in 
others there were no such association27. This leads to this 
unreliable correlation between IgA-s salivary levels and the 
menstrual period, even in those with association between 
the menstrual cycle and recurrent aphthous ulcerations28. 
Our series had only one woman (of the 12 females in the 
group) who reported having aphthous ulcerations at the 
time of menstruation.
CONCLUSION
Our results suggest a strong correlation between 
IgA-s and the lesion mechanisms in recurrent aphthous 
ulcerations, and this may be used as a parameter to assess 
the mucosal immune status.
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